Directorate Change

GlaxoSmithKline PLC
10 February 2003


                  Change in responsibilities of Board members

The Board of GlaxoSmithKline has reviewed the roles and responsibilities of the
company's Non-Executive Directors. Consequently, the following appointments have
been made, taking advantage of the skills and breadth of experience of the
company's Directors. The changes took effect from 7th February 2003:


        Nominations Committee

        Sir Ian Prosser has been appointed Chairman of the Nominations Committee
        in place of Sir Christopher Hogg who will remain a member of the
        Committee.


        Remuneration Committee

        Sir Peter Job has been appointed a member of the Remuneration Committee.


        Corporate Social Responsibility Committee

        Mr Donald McHenry has been appointed Chairman of the Corporate Social
        Responsibility Committee in place of Sir Christopher Hogg who will
        remain a member of the Committee.


S M Bicknell

Company Secretary

10th February 2003



                      This information is provided by RNS
            The company news service from the London Stock Exchange